breast cancers

ROANOKE, Va. - Runners came to Roanoke Saturday to help raise money and awareness for breast cancer in the annual Race for the Cure. See the video above for more. Copyright 2018 by WSLS 10 - All rights reserved. Get email alerts for local stories and events around the world. Sign Up. Powered by: ...

In many cancer types — especially in the case of breast cancer — surgery is often preferred when it comes to removing primary tumors. However, the recurrence of cancer after surgery is not an uncommon occurrence. Some who have gone through surgery are at an increased risk of early recurrence, ...

The use of postmasstectomy radiation has historically been a controversial topic in patients with 1 to 3 positive lymph nodes, according to Laura M. Freedman, MD. Revisions to the National Comprehensive Cancer Network (NCCN) guidelines have, however, have now allowed physicians to pinpoint the ...

More encouragingly, updated results of the SOFT trial demonstrated that the addition of ovarian suppression in the adjuvant setting benefited patients with premenopausal breast cancer. Likewise, the TEXT trial found that the use of adjuvant exemestane plus ovarian suppression resulted in a 91.1% ...

There are multiple therapeutic options in development for the treatment of patients with HER2-positive breast cancer, further adding to the regimens ... in heavily pretreated patients with HER2-expressing metastatic breast cancers who previously received ado-trastuzumab emtansine (T-DM1; Kadcyla).

At 47, I was a decade and a half younger than the median age for breast cancer diagnosis in the United States. Was this just bad luck? Maybe, but the journalist in me was still curious to know: Why me? So I dug into the literature on risk factors to see where I might have fit in. It's an impossible question to answer definitively ...

Abemaciclib (Verzenio) joined palbociclib (Ibrance) and ribociclib (Kisqali) as the third CDK 4/6 inhibitor for patients with hormone receptor (HR)-positive, HER2-negative breast cancer. Most recently, abemaciclib was approved by the FDA in February 2018 for use in the frontline setting in combination with ...

The European Medicines Agency has agreed to review an application by AstraZeneca and MSD requesting the approval of Lynparza (olaparib) for the treatment of patients with a difficult-to-treat type of metastatic breast cancer who previously received chemotherapy. The Marketing Authorization ...

Susan Domchek, MD, director of the Basser Center for BRCA at Penn Medicine, discusses areas of investigation in breast cancer. Things that physicians are looking at as predictors of response to chemotherapy include how many tumor infiltrating lymphocytes (TILs) are at baseline and what the immune ...

The study provides evidence of the potential importance of establishing a minimum recall rate for breast cancer screening programs, the researchers say. Calling women back for additional testing after suspicious mammography findings helps safeguard against missing invasive breast cancers, but carries ...

Scientists have identified a molecule that connects a biochemical pathway used by cancer cells to generate energy and regulates an oncogene that drives the progression of breast cancer and other tumor types. The studies, by a team at Baylor College of Medicine and Roswell Park Comprehensive Cancer ...

MSD and AstraZeneca's Lynparza will be the first PARP inhibitor to be reviewed in Europe for the treatment of breast cancer, after the European Medicines Agency validated the drug's marketing application in this setting. The companies are seeking permission to market the drug for use in patients with ...

Researchers from New Mexico, Massachusetts, Pennsylvania, Washington, New Hampshire, North Carolina, and California, performed a prospective cohort study to determine how often MR imaging was used for breast cancer screening among women who do and do not meet professional society ...

The Trump administration's Department of Health and Human Services (HHS) erased important information on breast cancer screenings and Affordable Care Act (aka Obamacare) benefits related to breast cancer from its women's health website with no warning, according to a report by the transparency ...

OlympiAD included 302 patients with HER2-negative metastatic breast cancer who harbored germline BRCA1 or BRCA2 mutations. Patients were recruited in 19 countries across Europe, Asia, North America, and South America, and received up to 2 prior lines of chemotherapy in the metastatic setting.

During the 5 year screening period, 666 invasive breast cancers were diagnosed in the mammography arm and 524 in the control arm. Of those, 180 women in the mammography arm and 171 women in the control arm died of breast cancer during the 25 year follow-up period, a non-significance difference ...

Estrogen levels are 15% higher on average in women with postmenopausal breast cancer, and the cancer risk is doubled at the highest levels, especially in those with both estrogen and progesterone receptors. Any increase in mean serum estrogens is associated with a higher risk of breast cancer ...

RICHMOND, Va. -- There is a new one-stop shop for breast cancer patients at Massey Cancer Center at Stony Point. The Breast Cancer Collaborative Care Clinic opened for women newly diagnosed with breast cancer. "Seems like it reduced some of the stress and anxiety to be able to have every single ...

Misconceptions and fears that many breast cancer patients facing radiation therapy have are typically not realized because of modern techniques, researchers report. Indeed, an overwhelming majority of patients surveyed for this study — comparing pretreatment beliefs with experiences — agreed that ...

The Food and Drug Administration for the first time has authorized a genetic testing company to offer screenings for three breast cancer mutations common in Ashkenazi Jews, giving consumers the ability to initiate testing at home and see results without talking to a doctor or counselor. The agency's action ...

Cancer Net Japan, a Tokyo-based nonprofit organization, recently organized an event to bring together male patients being treated for breast cancer and generate greater public understanding of the disease. In 2015, more than 87,000 people were newly diagnosed with breast cancer in Japan. Less than 1 ...

Older women residing in the U.S territories are less likely to receive recommended or timely care for breast cancer compared with similar women residing in the continental United States, according to Yale researchers. Their findings were published in the March issue of Health Affairs. Using Medicare ...

She was diagnosed with Stage 2b HER2-positive breast cancer in 2010. Website: www.feliciamitchell.net. A lump in the breast! It can be daunting, even if it turns out to be benign. A fibroadenoma, for example, is a lump of glandular and connective tissue with little or no risk of becoming cancerous. I was first ...

Dr. Gertraud Maskarinec, a preventive medicine physician and nutritional epidemiologist at the University of Hawaii Cancer Center, says that while there isn't a so-called "best diet" for preventing or dealing with breast cancer, avoiding obesity is important. "In terms of breast cancer and what we know about ...

“So, while our treatments have improved over the years, unfortunately, we still know that we have a lot of locally advanced breast cancer where women are presenting with large lumps which they can already feel or which their doctors have found upon examination. It is these women who do not do well with ...

A Mexican company, Higia Technologies, recently launched a new bra that detects breast cancer. They call it Eva and it promises to revolutionize the fashion market by linking it to health. Eva has two patches with biosensors placed in a radial pattern around the user's breasts. Cancerous tumors can cause ...

Engineering researchers at the University of Arkansas have moved closer to developing an alternative method of detecting and possibly treating breast cancer. The researchers, led by Magda El-Shenawee, professor of electrical engineering, work with pulsed, terahertz imaging, a type of electromagnetic ...

In March 2017, the U.S. Food and Drug Administration approved palbociclib for metastatic breast cancer in postmenopausal women in conjunction with Letrozole. Pfizer manufactures the drug under the brand name Ibrance. In November 2017, the National Health Service (NHS) of England approved the ...

Breast cancer spreads to other organs in the body according to certain specific patterns. This has been shown by a team of researchers from Karolinska Institutet and KTH in Sweden and the University of Helsinki in Finland who have mapped breast cancer's spread routes in patients by studying the cancer ...

Their work, published this month in the journal The Lancet Oncology, has led to the identification of the earliest known pictorial depictions of breast cancer. Signs of the disease were found in the oil panel transposition of Michelangelo's statue The Night, painted by Michele di Rodolfo del Ghirlandaio (also ...

Patricia Cook, head of Union County Elementary School in Georgia, was diagnosed with breast cancer in 2017. Student Jayden Rogers, 11, was one of ... Interested in Breast Cancer? Add Breast Cancer as an interest to stay up to date on the latest Breast Cancer news, video, and analysis from ABC News.

Women and their doctors need a greater understanding of the risks of cancer in dense breasts, an MP has warned. A woman with dense breasts - those with more glandular tissue - could be six times more likely to develop breast cancer. At the same time, it can also be harder to detect tumours in dense ...

However, in the largest study of its kind so far, scientists have now shown that the risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average population. Good risk management in the hospitals as well as control screenings at ...

... the ACR/SBI reclassification of African-American women, including statistics such as African-American women are 42 percent more likely to die from breast cancer than non-Hispanic white women despite comparable incidence rates, and black women have twice the risk of triple-negative breast cancers, ...